05/09/2005 - Novartis has offered to buy the remaining shares it does not already own in US headquartered Chiron for $4.5 billion, laying to rest speculation in the marketplace that it had been eyeing up Germany’s Schering AG.
Link to Article
In-PharmaTechnologist.com
|
|
||||
|
Monday, September 5
Novartis offers $4.5bn for control of Chiron
by
Alex Hsieh on behalf of Professor Henry Wang
on Mon 05 Sep 2005 11:30 PM EDT
|
Search
Links
|
|||